References
- Wall PG, Porter K, Noone A, Goldberg DJ. Changing incidence of Pneumocystis carinii pneumonia as initial AIDS defining disease in the United Kingdom. AIDS 1993; 7: 1523–5.
- Walzer PD, Schultz MG, Western KA, Robbins JB. Pneumocystis carinii pneumonia and primary immune deficiency diseases of infancy and childhood. Pediatrics 1973; 82: 416–22.
- Gigliotti F, og Hughes W. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii in animal models. J Clin Invest 1988; 81: 1666–8.
- Pesanti EL, Shanley JD. Glycoproteins of Pneumocystis carinii: Characterization by electrophoresis and microscopy. J Infect Dis 1988; 158: 153–9.
- Linke MJ, Cushion MT, Walzer PD. Properties of the major antigens of rat and human Pneumocystis carinii. Infect Immun 1989; 57: 1547–55.
- Kovacs JA, Halpern JL, Swan JC, Moss J, Parillo JE, Masur H. Identification of antigens and antibodies specific for Pneumocystis carinii. J Immunol 1988; 140: 2023–31.
- Kovacs JA, Halpern JL, Lundgren B, Swan JC, Parillo JE, Masur H. Monoclonal antibodies to Pneumocystis carinii: Identification of specific antigens and characterization of antigenic differences between rat and human isolates. J Infect Dis 1989; 159: 60–70.
- Walzer PD, Powell RD jr, Yoneda ME, Milder JE. Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia. Infect Immun 1980; 27: 928–37.
- Laursen AL, Andersen PL. Serum antibodies directed against Pneumocystis carinii in patients with AIDS. Immunol Infect Dis 1992; 2: 275–80.
- Maddison SE, Hayes GV, Ivey MH, Tsang VW, Slemenda SB, Norman LG. Fractionation of Pneumocystis carinii antigens used in an enzyme-linked immunosorbent assay for antibodies and in the production of antiserum for detecting Pneumocystis carinii antigenemia. J Clin Microbiol 1982; 15: 1029–35.
- Linke MJ, Cushion MT, Walzer PD. Properties of major antigens of rat and human Pneumocystis carinii. Infect Immun 1989; 57: 1547–55.
- Lundgren B, Lipschik GY, Kovacs JA. Purification and characterization of a major human Pneumocystis carinii surface antigen. J Clin Invest 1991; 87: 163–1670.
- Pottratz ST, Paulsrud JR, Smith JS, Martin II WJ. Evidence for Pneumocystis carinii binding to a cell-free substrate: Role of the adhesive protein fibronectin. J Lab Clin Med 1994; 123: 273–81.
- Gigliotti F. Host species-specific antigenic variations of a mannosylated surface glucoprotein of Pneumocystis carinii. J Infect Dis 1992; 165: 329–36.
- Maddison SE, Walls KW, Haverkos HW, Juranek DD. Evaluation of serologic tests for Pneumocystis carinii antibody and antigenemia in patients with immunodeficiency syndrome. Diagn Microbiol Infect Dis 1984; 2: 69–73.
- Graves DC, McNabb SJN, Worley MA, Downs TD, Ivey MH. Analyses of rat Pneumocystis carinii antigens recognized by human and rat antibodies by using western immunoblotting. Infect Immun 1986; 54: 96–103.
- Pifer LLW, Niell HB, Langdon SB, Baltz S, Clark ST, Edwards CC, Woods DR. Evidence for depressed humoral immunity to Pneumocystis carinii in homosexual males, commercial plasma donors, and patients with acquired immunodeficiency syndrome. J Clin Microbiol 1987; 25: 991–5.
- Salim YS, Faber V, Wiik A, Andersen PL, Høier-Madsen M, Mouritsen S. Anti-corticosteroid antibodies in AIDS patients. APMIS 1988; 96: 889–94.
- Lundgren B, Lundgren JD, Nielsen T, Mathiesen L, Nielsen JO, Kovacs JA. Antibody responses to a major Pneumocystis carinii antigen in human immunodeficiency virus-infected patients with and without P. carinii pneumonia. J Infect Dis 1992; 165: 1151–5.
- Pifer LL. Dynamics of Pneumocystis carinii-specific immune complexes in AIDS patients with P. cariniipneumonia. J Protozool 1989; 36: 44s–5s.